These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39025034)

  • 1. The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial.
    Mohammad Soleymani S; Assarzadegan F; Habibi SAH; Mahboubi A; Esmaily H
    Parkinsonism Relat Disord; 2024 Sep; 126():107051. PubMed ID: 39025034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial.
    Guo X; Cui H; Zhang H; Guan X; Zhang Z; Jia C; Wu J; Yang H; Qiu W; Zhang C; Yang Z; Chen Z; Mao G
    Medicine (Baltimore); 2015 Nov; 94(45):e1872. PubMed ID: 26559255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial.
    Ghiasian M; Khamisabadi F; Kheiripour N; Karami M; Haddadi R; Ghaleiha A; Taghvaei B; Oliaie SS; Salehi M; Samadi P; Ranjbar A
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22410. PubMed ID: 31617649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research.
    Goyal A; Verma A; Agrawal A; Dubey N; Kumar A; Behl T
    Chem Biol Drug Des; 2023 Jun; 101(6):1229-1240. PubMed ID: 36752710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    Park MS; Park S; Kang JY; Jung IC; Yoo H
    PLoS One; 2024; 19(5):e0303156. PubMed ID: 38709746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocin protects PC12 cells against MPP(+)-induced injury through inhibition of mitochondrial dysfunction and ER stress.
    Zhang GF; Zhang Y; Zhao G
    Neurochem Int; 2015 Oct; 89():101-10. PubMed ID: 26209153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA versus RNA oxidation in Parkinson's disease: Which is more important?
    Gmitterová K; Gawinecka J; Heinemann U; Valkovič P; Zerr I
    Neurosci Lett; 2018 Jan; 662():22-28. PubMed ID: 28963060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
    Talaei A; Hassanpour Moghadam M; Sajadi Tabassi SA; Mohajeri SA
    J Affect Disord; 2015 Mar; 174():51-6. PubMed ID: 25484177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.
    Bozorgi H; Ghahremanfard F; Motaghi E; Zamaemifard M; Zamani M; Izadi A
    J Ethnopharmacol; 2021 Dec; 281():114511. PubMed ID: 34390797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
    Jankovic J; Hunter C
    Parkinsonism Relat Disord; 2002 Mar; 8(4):271-6. PubMed ID: 12039422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of intermittent hypoxia in Parkinson's disease: study rationale and protocol.
    Janssen Daalen JM; Meinders MJ; Mathur S; van Hees HWH; Ainslie PN; Thijssen DHJ; Bloem BR
    BMC Neurol; 2024 Jun; 24(1):212. PubMed ID: 38909201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial.
    Ghodsi H; Rahimi HR; Aghili SM; Saberi A; Shoeibi A
    Clin Neurol Neurosurg; 2022 Jul; 218():107300. PubMed ID: 35636380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
    Bogdanov M; Matson WR; Wang L; Matson T; Saunders-Pullman R; Bressman SS; Flint Beal M
    Brain; 2008 Feb; 131(Pt 2):389-96. PubMed ID: 18222993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Bushen Huoxue Granule on motor function in patients with Parkinson's disease: a multicenter, randomized, double-blind and placebo-controlled trial].
    Yang MH; Li M; Dou YQ; Liu Y; Luo XD; Chen JZ; Shi HJ
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):231-7. PubMed ID: 20226144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
    Carroll CB; Webb D; Stevens KN; Vickery J; Eyre V; Ball S; Wyse R; Webber M; Foggo A; Zajicek J; Whone A; Creanor S
    BMJ Open; 2019 Oct; 9(10):e029740. PubMed ID: 31594876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism.
    Rao SV; Muralidhara ; Yenisetti SC; Rajini PS
    Neurotoxicology; 2016 Jan; 52():230-42. PubMed ID: 26705857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.